Streck has joined forces with Longhorn Vaccines and Diagnostics to distribute its flagship product, PrimeStore Molecular Transport Media (MTM), worldwide.

PrimeStore MTM is an FDA-cleared collection device for inactivation, stabilization and ambient temperature transportation of biological samples.

"Streck is a true innovator in the sample collection field, and one of the most trusted companies in the diagnostic industry," said Jeff Fischer, co-founder and president of Longhorn.

"PrimeStore MTM is a natural fit for distribution by Streck, as Longhorn shares its dedication to providing unique stabilization solutions for clinical testing and research," Fischer added.

"Streck is excited to enter the transport media space with a partner whose products have transformed the field," said Matthew Kreifels, vice president of Sales, MarCom, and Business Development at Streck.

"We look forward to sharing this molecular testing tool with labs worldwide," Kreifels added.

Nucleic acid-based testing can rapidly identify infection-causing pathogens, providing the necessary information for healthcare professionals to quickly implement appropriate and effective treatment strategies. However, the collection, transport and handling of infectious disease specimens is often complicated by safety concerns for personnel involved in testing and the inherent instability of the microbial nucleic acids of interest. With PrimeStore MTM, the transport and testing process is streamlined and safe.

Streck develops quality control and sample stabilization products that help clinical and research laboratories worldwide feel confident in the validity of their results. Streck products are manufactured in La Vista, Nebraska, and delivered to thousands of labs worldwide.